Clozapine Increases Risk Of Metabolic Syndrome

by Medindia Content Team on  July 2, 2006 at 3:13 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Clozapine Increases Risk Of Metabolic Syndrome
Researchers at University of Rochester Medical Centre say that the antipsychotic drug, clozapine has some very concerning side effects. Clopazine is the most effective anti-psychotic drug available.

"Clozapine is the last hope for many people. But there are long-term health implications. This study suggests that patients who need the most effective medication are between a rock and a hard place," said J. Steven Lamberti, the lead author of the study.

The study found that clozapine increased the risk of metabolic syndrome, a group of conditions that increase the risk for heart disease, stroke and diabetes.

The details of the study appear in latest issue of The American Journal of Psychiatry. The study said that the potential risks must be weighed with the benefits.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Schizophrenia Metabolic Syndrome Syndrome X 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive